|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM342365029 |
003 |
DE-627 |
005 |
20231226013938.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2022 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1021/acs.langmuir.2c00794
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1141.xml
|
035 |
|
|
|a (DE-627)NLM342365029
|
035 |
|
|
|a (NLM)35715215
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Hu, Taishun
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Multichannel Ca2+ Generator for Synergistic Tumor Therapy via Intracellular Ca2+ Overload and Chemotherapy
|
264 |
|
1 |
|c 2022
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 07.07.2022
|
500 |
|
|
|a Date Revised 24.08.2022
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Ca2+ overload has attracted an increasing attention due to its benefit of precise cancer therapy, but its efficacy is limited by the strong Ca2+ excretion of cancer cells. Moreover, monotherapy of Ca2+ overload usually fails to treat tumors satisfactorily. Herein, we develop a multifunctional nanosystem that could induce Ca2+ overload by multipathway and simultaneously produce chemotherapy for synergistic tumor therapy. The nanosystem (CaMSNCUR) is prepared by synthesizing a Ca-doped mesoporous silica nanoparticle (CaMSN) followed by loading the anticancer drug curcumin (CUR). CaMSN serves as the basis Ca2+ generator to induce Ca2+ overload directly in the intracellular environment by acid-triggered Ca2+ release, while CUR could not only exhibit chemotherapy but also facilitate Ca2+ release from the endoplasmic reticulum to the cytoplasm and inhibit Ca2+ efflux out of cells to further enhance Ca2+ overload. The in vitro and in vivo results show that CaMSN@CUR could exhibit a remarkable cytotoxicity against 4T1 cells and significantly inhibit tumor growth in 4T1 tumor-bearing mice via the synergy of Ca2+ overload and CUR-mediated chemotherapy. It is expected that the designed CaMSN@CUR has a great potential for effective tumor therapy
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Antineoplastic Agents
|2 NLM
|
650 |
|
7 |
|a Drug Carriers
|2 NLM
|
650 |
|
7 |
|a Silicon Dioxide
|2 NLM
|
650 |
|
7 |
|a 7631-86-9
|2 NLM
|
650 |
|
7 |
|a Curcumin
|2 NLM
|
650 |
|
7 |
|a IT942ZTH98
|2 NLM
|
700 |
1 |
|
|a Liu, Xinli
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gong, Xiyu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chen, Botao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tan, Songwen
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Xu, Hui
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Pan, Anqiang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Liang, Shuquan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a He, Yongju
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhou, Fangfang
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Langmuir : the ACS journal of surfaces and colloids
|d 1992
|g 38(2022), 26 vom: 05. Juli, Seite 8012-8020
|w (DE-627)NLM098181009
|x 1520-5827
|7 nnns
|
773 |
1 |
8 |
|g volume:38
|g year:2022
|g number:26
|g day:05
|g month:07
|g pages:8012-8020
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1021/acs.langmuir.2c00794
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_721
|
951 |
|
|
|a AR
|
952 |
|
|
|d 38
|j 2022
|e 26
|b 05
|c 07
|h 8012-8020
|